Press Releases

Latest

AstraZeneca and Luye Pharma Group enter agreement for rights to Seroquel and Seroquel XR in the UK, China and other international markets
7 May 2018
Tagrisso receives positive EU CHMP opinion for 1st-line treatment of EGFR-mutated non-small cell lung cancer
27 April 2018
AstraZeneca reports results from the ARCTIC trial in third-line non-small cell lung cancer
24 April 2018
US FDA approves Tagrisso as 1st-line treatment for EGFR-mutated non-small cell lung cancer
18 April 2018
Updated overall survival data for Lynparza in BRCA-mutated HER2-negative metastatic breast cancer presented at AACR
15 April 2018
1st-line Tagrisso demonstrates sustained benefit post progression in patients with EGFR-mutated non-small cell lung cancer
13 April 2018
AstraZeneca’s early and late-stage oncology portfolio showcased at AACR annual meeting and ELCC
4 April 2018
US FDA accepts Biologics License Application for moxetumomab pasudotox in hairy cell leukaemia
3 April 2018
The European Medicines Agency accepts regulatory submission for Lynparza in BRCA-mutated HER2-negative metastatic breast cancer
3 April 2018
Lokelma approved in the EU for the treatment of adults with hyperkalaemia
22 March 2018

Can't find what you are looking for? Our Press Release archive contains all of our press releases dated before 2011 so you should be able to find just what you are looking for.

Explore archive

Contact us

Karen Birmingham

Director Global Science Media

+44 203 749 5634

Rob Skelding

Director Global Media Relations

+44 203 749 5821

Matthew Kent

Director Global Media Relations

+44 203 749 5906

Gonzalo Viña

Director Global Media Relations

+44 203 749 5916

Jacob Lund

Director External Communications, Sweden

+46 8 553 260 20

Lotta Sjösten

Manager Media Relations, Sweden

+46 8 553 271 10

US Media Team

+1 302 885 2677

Press Releases

Contact us

Subscribe

Follow us

LinkedIn